{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV001281540","releaseDate":"2021-01-17","targetFromSourceId":"ENSG00000061455","variantFunctionalConsequenceId":"SO_0001583","variantId":"5_123159516_C_T","variantRsId":"rs1333586171","cohortPhenotypes":["Heart, malformation of"],"diseaseFromSource":"Heart, malformation of","diseaseFromSourceId":"CN130023","diseaseFromSourceMappedId":"HP_0001627","variantHgvsId":"NC_000005.10:g.123159516C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002030146","releaseDate":"2022-03-28","targetFromSourceId":"ENSG00000160200","variantFunctionalConsequenceId":"SO_0001583","variantId":"21_43063980_T_C","variantRsId":"rs777884368","cohortPhenotypes":["HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED"],"diseaseFromSource":"HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED","diseaseFromSourceId":"C3150344","diseaseFromSourceMappedId":"Orphanet_394","variantHgvsId":"NC_000021.9:g.43063980T>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["pathogenic"],"confidence":"no assertion criteria provided","studyId":"RCV000412534","releaseDate":"2017-01-09","targetFromSourceId":"ENSG00000139324","variantFunctionalConsequenceId":"SO_0001587","variantId":"12_88195521_C_T","variantRsId":"rs1057517697","cohortPhenotypes":["Lissencephaly 8"],"diseaseFromSource":"Lissencephaly 8","diseaseFromSourceId":"C4310646","diseaseFromSourceMappedId":"MONDO_0018838","variantHgvsId":"NC_000012.12:g.88195521C>T"}
{"alleleOrigins":null,"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV000987058","releaseDate":"2020-01-11","targetFromSourceId":"ENSG00000130561","variantFunctionalConsequenceId":"SO_0001587","variantId":"2_233328536_C_T","variantRsId":"rs1574942567","cohortPhenotypes":["Oguchi disease","Oguchi's disease","Stationary night blindness, Oguchi type"],"diseaseFromSource":"Oguchi disease","diseaseFromSourceId":"C1306122","diseaseFromSourceMappedId":"MONDO_0019152","variantHgvsId":"NC_000002.12:g.233328536C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV000850771","releaseDate":"2019-09-22","targetFromSourceId":"ENSG00000198804","variantFunctionalConsequenceId":"SO_0001631","variantId":"MT_4456_C_T","variantRsId":"rs1603219465","cohortPhenotypes":["Juvenile myopathy, encephalopathy, lactic acidosis AND stroke","MELAS syndrome","Mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes"],"diseaseFromSource":"Juvenile myopathy, encephalopathy, lactic acidosis AND stroke","diseaseFromSourceId":"C0162671","diseaseFromSourceMappedId":"Orphanet_550","variantHgvsId":"NC_012920.1:m.4456C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, multiple submitters, no conflicts","studyId":"RCV001223098","releaseDate":"2020-07-16","targetFromSourceId":"ENSG00000104133","variantFunctionalConsequenceId":"SO_0001583","variantId":"15_44598352_G_C","variantRsId":"rs746116309","cohortPhenotypes":["Autosomal recessive hereditary spastic paraplegia, mental impairment, and thin corpus callosum","Hereditary spastic paraplegia 11","Hereditary spastic paraplegia mental impairment and thin corpus callosum","Nakamura Osame syndrome","SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM","SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM","Spastic paraplegia 11","Spastic paraplegia 11, autosomal recessive","Spastic paraplegia,  mental retardation and thin corpus callosum"],"diseaseFromSource":"Hereditary spastic paraplegia 11","diseaseFromSourceId":"C1858479","diseaseFromSourceMappedId":"MONDO_0011445","variantHgvsId":"NC_000015.10:g.44598352G>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV000279062","releaseDate":"2016-12-06","targetFromSourceId":"ENSG00000175294","variantFunctionalConsequenceId":"SO_0001819","variantId":"11_66025978_C_T","variantRsId":"rs370953416","cohortPhenotypes":["CATSPER-Related Male Infertility","MALE INFERTILITY, NONSYNDROMIC, AUTOSOMAL RECESSIVE","Spermatogenic failure 7"],"diseaseFromSource":"Spermatogenic failure 7","diseaseFromSourceId":"C2751811","diseaseFromSourceMappedId":"MONDO_0013070","variantHgvsId":"NC_000011.10:g.66025978C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV003236645","releaseDate":"2023-06-24","targetFromSourceId":"ENSG00000184895","variantFunctionalConsequenceId":"SO_0001583","variantId":"Y_2787299_G_A","variantRsId":null,"cohortPhenotypes":["46,XX SEX REVERSAL, SRY-POSITIVE","46,XX sex reversal 1","SRY-positive 46,XX testicular disorder of sex development"],"diseaseFromSource":"46,XX sex reversal 1","diseaseFromSourceId":"C2748895","diseaseFromSourceMappedId":"MONDO_0100250","variantHgvsId":"NC_000024.10:g.2787299G>A"}
{"alleleOrigins":null,"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV000671195","releaseDate":"2018-08-05","targetFromSourceId":"ENSG00000170927","variantFunctionalConsequenceId":"SO_0001822","variantId":"6_51748030_CTTT_C","variantRsId":"rs1554218479","cohortPhenotypes":["AR polycystic kidney disease","Autosomal recessive polycystic kidney disease","POLYCYSTIC KIDNEY AND HEPATIC DISEASE 1","POLYCYSTIC KIDNEY DISEASE, INFANTILE, TYPE I","Polycystic kidney disease, infantile type"],"diseaseFromSource":"Autosomal recessive polycystic kidney disease","diseaseFromSourceId":"C0085548","diseaseFromSourceMappedId":"MONDO_0009889","variantHgvsId":"NC_000006.12:g.51748034_51748036del"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"no assertion criteria provided","studyId":"RCV003389101","releaseDate":"2023-11-11","targetFromSourceId":"ENSG00000114374","variantFunctionalConsequenceId":"SO_0001583","variantId":"Y_12842370_G_T","variantRsId":null,"cohortPhenotypes":["AZOOSPERMIA, NONOBSTRUCTIVE, Y-LINKED","OLIGOSPERMIA, NONOBSTRUCTIVE, Y-LINKED","OLIGOZOOSPERMIA, NONOBSTRUCTIVE, Y-LINKED","SPERMATOGENIC ARREST, Y-LINKED","SPERMATOGENIC FAILURE, NONOBSTRUCTIVE, Y-LINKED","Spermatogenic failure, Y-linked, 2"],"diseaseFromSource":"Spermatogenic failure, Y-linked, 2","diseaseFromSourceId":"C1839071","diseaseFromSourceMappedId":"MONDO_0015607","variantHgvsId":"NC_000024.10:g.12842370G>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV002083386","releaseDate":"2022-04-08","targetFromSourceId":"ENSG00000072778","variantFunctionalConsequenceId":"SO_0002169","variantId":"17_7224135_T_C","variantRsId":"rs745620433","cohortPhenotypes":["VLCAD deficiency","Very long chain acyl-CoA dehydrogenase deficiency"],"diseaseFromSource":"Very long chain acyl-CoA dehydrogenase deficiency","diseaseFromSourceId":"C3887523","diseaseFromSourceMappedId":"MONDO_0008723","variantHgvsId":"NC_000017.11:g.7224135T>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV002203969","releaseDate":"2022-04-12","targetFromSourceId":"ENSG00000125741","variantFunctionalConsequenceId":"SO_0001819","variantId":"19_45584735_C_T","variantRsId":"rs1131692018","cohortPhenotypes":["3-Methylglutaconic aciduria type 3","3-alpha methylglutaconic aciduria type III","3-methylglutaconic aciduria type III","Costeff optic atrophy syndrome","Iraqi Jewish optic atrophy plus","MGA type III","OPA3, AUTOSOMAL RECESSIVE","OPA3-Related 3-Methylglutaconic Aciduria","OPTIC ATROPHY 3, AUTOSOMAL DOMINANT","OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE","Optic atrophy 3","Optic atrophy and cataract, autosomal dominant","Optic atrophy infantile with chorea and spastic paraplegia","Optic atrophy, cataract, and neurologic disorder"],"diseaseFromSource":"Optic atrophy 3","diseaseFromSourceId":"C1833809","diseaseFromSourceMappedId":"Orphanet_67036","variantHgvsId":"NC_000019.10:g.45584735C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002676812","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000125826","variantFunctionalConsequenceId":"SO_0001583","variantId":"20_419394_C_A","variantRsId":null,"cohortPhenotypes":["POLYGLUCOSAN BODY MYOPATHY WITHOUT IMMUNODEFICIENCY","Polyglucosan body myopathy 1 with or without immunodeficiency","Polyglucosan body myopathy type 1"],"diseaseFromSource":"Polyglucosan body myopathy type 1","diseaseFromSourceId":"C4014605","diseaseFromSourceMappedId":"Orphanet_397937","variantHgvsId":"NC_000020.11:g.419394C>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002680839","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000160789","variantFunctionalConsequenceId":"SO_0001583","variantId":"1_156137732_C_T","variantRsId":null,"cohortPhenotypes":["Charcot-Marie-Tooth disease type 2","Charcot-Marie-Tooth, Type 2"],"diseaseFromSource":"Charcot-Marie-Tooth disease type 2","diseaseFromSourceId":"C0270914","diseaseFromSourceMappedId":"MONDO_0018993","variantHgvsId":"NC_000001.11:g.156137732C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV002847567","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000075891","variantFunctionalConsequenceId":"SO_0001589","variantId":"10_100750706_C_CG","variantRsId":null,"cohortPhenotypes":["CAKUT WITH OR WITHOUT OCULAR ABNORMALITIES","CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT WITH OR WITHOUT OCULAR ABNORMALITIES","Coloboma of optic nerve with renal disease","Focal segmental glomerulosclerosis 7","Optic coloboma, vesicoureteral reflux, and renal anomalies","Optic nerve coloboma with renal disease","PAPILLORENAL SYNDROME WITH MILD OCULAR ABNORMALITIES","Papillorenal syndrome","RENAL-COLOBOMA SYNDROME WITH MACULAR ABNORMALITIES","Renal coloboma syndrome"],"diseaseFromSource":"Focal segmental glomerulosclerosis 7","diseaseFromSourceId":"C4014925","diseaseFromSourceMappedId":"MONDO_0014451","variantHgvsId":"NC_000010.11:g.100750708dup"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003621924","releaseDate":"2024-02-20","targetFromSourceId":"ENSG00000008056","variantFunctionalConsequenceId":"SO_0001819","variantId":"X_47619585_G_C","variantRsId":null,"cohortPhenotypes":["Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders","Epilepsy, X-linked, with variable learning disabilities and behavior disorders","X-linked epilepsy-learning disabilities-behavior disorders syndrome"],"diseaseFromSource":"Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders","diseaseFromSourceId":"C5774177","diseaseFromSourceMappedId":"Orphanet_85294","variantHgvsId":"NC_000023.11:g.47619585G>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003636240","releaseDate":"2024-02-20","targetFromSourceId":"ENSG00000143669","variantFunctionalConsequenceId":"SO_0001819","variantId":"1_235744114_A_G","variantRsId":null,"cohortPhenotypes":["Chediak-Higashi Syndrome","Chédiak-Higashi syndrome"],"diseaseFromSource":"Chédiak-Higashi syndrome","diseaseFromSourceId":"C0007965","diseaseFromSourceMappedId":"Orphanet_167","variantHgvsId":"NC_000001.11:g.235744114A>G"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV003735165","releaseDate":"2024-02-20","targetFromSourceId":"ENSG00000196569","variantFunctionalConsequenceId":"SO_0001575","variantId":"6_129453132_G_C","variantRsId":null,"cohortPhenotypes":["LAMA2-related muscular dystrophy","Laminin alpha 2-related dystrophy"],"diseaseFromSource":"LAMA2-related muscular dystrophy","diseaseFromSourceId":"C5679788","diseaseFromSourceMappedId":"MONDO_0100228","variantHgvsId":"NC_000006.12:g.129453132G>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV000797080","releaseDate":"2019-08-14","targetFromSourceId":"ENSG00000179348","variantFunctionalConsequenceId":"SO_0001583","variantId":"3_128485795_C_A","variantRsId":"rs1576748419","cohortPhenotypes":["COMBINED IMMUNODEFICIENCY WITH SUSCEPTIBILITY TO MYCOBACTERIAL, VIRAL, AND FUNGAL INFECTIONS","Deafness-lymphedema-leukemia syndrome","Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency","Emberger syndrome","GATA2 DEFICIENCY","IMMUNODEFICIENCY 21","Lymphedema, primary, with myelodysplasia","MONOCYTOPENIA AND MYCOBACTERIAL INFECTION SYNDROME","MONOCYTOPENIA WITH SUSCEPTIBILITY TO MYCOBACTERIAL, FUNGAL, AND PAPILLOMAVIRUS INFECTIONS AND MYELODYSPLASIA","Monocytopenia with susceptibility to infections"],"diseaseFromSource":"Monocytopenia with susceptibility to infections","diseaseFromSourceId":"C3280030","diseaseFromSourceMappedId":"MONDO_0013607","variantHgvsId":"NC_000003.12:g.128485795C>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV001500249","releaseDate":"2021-06-08","targetFromSourceId":"ENSG00000159082","variantFunctionalConsequenceId":"SO_0001819","variantId":"21_32694306_C_T","variantRsId":"rs780954414","cohortPhenotypes":["Developmental and epileptic encephalopathy, 53","Early-onset Parkinson disease 20","Epileptic encephalopathy, early infantile, 53"],"diseaseFromSource":"Developmental and epileptic encephalopathy, 53","diseaseFromSourceId":"C4479313","diseaseFromSourceMappedId":"Orphanet_1934","variantHgvsId":"NC_000021.9:g.32694306C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV002392200","releaseDate":"2022-11-29","targetFromSourceId":"ENSG00000184058","variantFunctionalConsequenceId":"SO_0001819","variantId":"22_19766420_C_T","variantRsId":null,"cohortPhenotypes":["Cardiovascular phenotype"],"diseaseFromSource":"Cardiovascular phenotype","diseaseFromSourceId":"CN230736","diseaseFromSourceMappedId":"HP_0001626","variantHgvsId":"NC_000022.11:g.19766420C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV003774575","releaseDate":"2024-02-28","targetFromSourceId":"ENSG00000128591","variantFunctionalConsequenceId":"SO_0001583","variantId":"7_128841305_G_A","variantRsId":null,"cohortPhenotypes":["Cardiomyopathy, familial hypertrophic, 26","Dilated Cardiomyopathy, Dominant","Distal myopathy with posterior leg and anterior hand involvement","FILAMINOPATHY, AUTOSOMAL DOMINANT","Filaminopathy (type)","Hypertrophic cardiomyopathy 26","Myofibrillar myopathy 5","Myofibrillar myopathy, filamin C-related","Myopathy, distal, 4","WILLIAMS DISTAL MYOPATHY"],"diseaseFromSource":"Hypertrophic cardiomyopathy 26","diseaseFromSourceId":"C4310749","diseaseFromSourceMappedId":"EFO_0000538","variantHgvsId":"NC_000007.14:g.128841305G>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV003779225","releaseDate":"2024-02-28","targetFromSourceId":"ENSG00000151929","variantFunctionalConsequenceId":"SO_0001821","variantId":"10_119670132_G_GGCA","variantRsId":null,"cohortPhenotypes":["Dilated cardiomyopathy 1HH","Myofibrillar myopathy 6","Myofibrillar myopathy, BAG3-related"],"diseaseFromSource":"Dilated cardiomyopathy 1HH","diseaseFromSourceId":"C3151293","diseaseFromSourceMappedId":"MONDO_0013479","variantHgvsId":"NC_000010.11:g.119670135_119670137dup"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV001490387","releaseDate":"2021-06-08","targetFromSourceId":"ENSG00000134853","variantFunctionalConsequenceId":"SO_0001627","variantId":"4_54287551_T_C","variantRsId":"rs2110341918","cohortPhenotypes":["Gastrointestinal Stromal Sarcoma","Gastrointestinal stroma tumor","Gastrointestinal stromal tumor","Gastrointestinal stromal tumor, somatic"],"diseaseFromSource":"Gastrointestinal stromal tumor","diseaseFromSourceId":"C0238198","diseaseFromSourceMappedId":"MONDO_0011719","variantHgvsId":"NC_000004.12:g.54287551T>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV003041098","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000007314","variantFunctionalConsequenceId":"SO_0001583","variantId":"17_63948745_A_T","variantRsId":null,"cohortPhenotypes":["Adynamia episodica hereditaria with or without myotonia","Familial hyperkalemic periodic paralysis","Gamstorp disease","Gamstorp episodic adynamy","Hyperkalemic periodic paralysis"],"diseaseFromSource":"Hyperkalemic periodic paralysis","diseaseFromSourceId":"C0238357","diseaseFromSourceMappedId":"MONDO_0008224","variantHgvsId":"NC_000017.11:g.63948745A>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003966094","releaseDate":"2024-03-16","targetFromSourceId":"ENSG00000164818","variantFunctionalConsequenceId":"SO_0001819","variantId":"7_756970_C_G","variantRsId":"rs571248637","cohortPhenotypes":["DNAAF5-related condition","DNAAF5-related disorder"],"diseaseFromSource":"DNAAF5-related disorder","diseaseFromSourceId":null,"diseaseFromSourceMappedId":null,"variantHgvsId":"NC_000007.14:g.756970C>G"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003921540","releaseDate":"2024-03-16","targetFromSourceId":"ENSG00000134982","variantFunctionalConsequenceId":"SO_0001623","variantId":"5_112738418_A_G","variantRsId":null,"cohortPhenotypes":["APC-related condition","APC-related disorder"],"diseaseFromSource":"APC-related disorder","diseaseFromSourceId":null,"diseaseFromSourceMappedId":null,"variantHgvsId":"NC_000005.10:g.112738418A>G"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV001340631","releaseDate":"2021-03-22","targetFromSourceId":"ENSG00000139618","variantFunctionalConsequenceId":"SO_0001583","variantId":"13_32340936_T_C","variantRsId":"rs876660049","cohortPhenotypes":["Breast and ovarian cancer","Hereditary breast and ovarian cancer","Hereditary breast and ovarian cancer syndrome","Hereditary breast and ovarian cancer syndrome (HBOC)","Hereditary breast ovarian cancer syndrome"],"diseaseFromSource":"Hereditary breast ovarian cancer syndrome","diseaseFromSourceId":"C0677776","diseaseFromSourceMappedId":"MONDO_0003582","variantHgvsId":"NC_000013.11:g.32340936T>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["conflicting interpretations of pathogenicity"],"confidence":"no assertion criteria provided","studyId":"RCV000056173","releaseDate":"2013-10-01","targetFromSourceId":"ENSG00000196218","variantFunctionalConsequenceId":"SO_0001583","variantId":"19_38585013_C_T","variantRsId":"rs118192153","cohortPhenotypes":["Central core disease","Central core disease of muscle","Central core myopathy","Muscle core disease","Muscular central core disease","Myopathy, central fibrillar","Shy-Magee syndrome"],"diseaseFromSource":"Central core myopathy","diseaseFromSourceId":"C0751951","diseaseFromSourceMappedId":"EFO_1000855","variantHgvsId":"NC_000019.10:g.38585013C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002249476","releaseDate":"2022-05-28","targetFromSourceId":"ENSG00000228253","variantFunctionalConsequenceId":"SO_0001631","variantId":"MT_7462_C_T","variantRsId":"rs1569484151","cohortPhenotypes":["COX deficiency","Complex 4 mitochondrial respiratory chain deficiency","Complex IV deficiency","Deficiency of mitochondrial respiratory chain complex4","Mitochondrial complex IV deficiency","Mitochondrial complex IV deficiency, nuclear type 1"],"diseaseFromSource":"Mitochondrial complex IV deficiency, nuclear type 1","diseaseFromSourceId":"C5435656","diseaseFromSourceMappedId":"MONDO_0859160","variantHgvsId":"NC_012920.1:m.7462C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003093847","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000130294","variantFunctionalConsequenceId":"SO_0001630","variantId":"2_240767028_G_C","variantRsId":"rs748724769","cohortPhenotypes":["Hereditary sensory and autonomic neuropathy type IIC","Hereditary spastic paraplegia 30","Intellectual disability, autosomal dominant 9","Mental retardation, autosomal dominant 9","NESCAV SYNDROME","Neuropathy, hereditary sensory, type 2C","SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT","Spastic paraplegia 30, autosomal recessive"],"diseaseFromSource":"Neuropathy, hereditary sensory, type 2C","diseaseFromSourceId":"C3280168","diseaseFromSourceMappedId":"Orphanet_970","variantHgvsId":"NC_000002.12:g.240767028G>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002016427","releaseDate":"2022-03-28","targetFromSourceId":"ENSG00000159884","variantFunctionalConsequenceId":"SO_0001631","variantId":"9_35657840_C_G","variantRsId":"rs1287720442","cohortPhenotypes":["Anauxetic dysplasia","SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE"],"diseaseFromSource":"Anauxetic dysplasia","diseaseFromSourceId":"C1846796","diseaseFromSourceMappedId":"MONDO_0011773","variantHgvsId":"NC_000009.12:g.35657840C>G"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002625025","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000054983","variantFunctionalConsequenceId":"SO_0001583","variantId":"14_87976417_C_A","variantRsId":null,"cohortPhenotypes":["Galactocerebrosidase deficiency","Galactosylceramide beta-galactosidase deficiency","Globoid cell leukoencephalopathy","Krabbe leukodystrophy","Leukodystrophy, Globoid Cell"],"diseaseFromSource":"Galactosylceramide beta-galactosidase deficiency","diseaseFromSourceId":"C0023521","diseaseFromSourceMappedId":"MONDO_0009499","variantHgvsId":"NC_000014.9:g.87976417C>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV003516889","releaseDate":"2024-02-14","targetFromSourceId":"ENSG00000046604","variantFunctionalConsequenceId":"SO_0001583","variantId":"18_31520935_C_A","variantRsId":null,"cohortPhenotypes":["ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10","Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy10","Arrhythmogenic right ventricular cardiomyopathy, type 10","Arrhythmogenic right ventricular dysplasia 10","Arrhythmogenic right ventricular dysplasia/cardiomyopathy, type 10"],"diseaseFromSource":"Arrhythmogenic right ventricular dysplasia 10","diseaseFromSourceId":"C1857777","diseaseFromSourceMappedId":"Orphanet_247","variantHgvsId":"NC_000018.10:g.31520935C>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV003583433","releaseDate":"2024-02-14","targetFromSourceId":"ENSG00000163932","variantFunctionalConsequenceId":"SO_0001583","variantId":"3_53186260_A_G","variantRsId":null,"cohortPhenotypes":["Autoimmune lymphoproliferative syndrome, type III","Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD"],"diseaseFromSource":"Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD","diseaseFromSourceId":"C3809928","diseaseFromSourceMappedId":"Orphanet_3261","variantHgvsId":"NC_000003.12:g.53186260A>G"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV001419044","releaseDate":"2021-05-16","targetFromSourceId":"ENSG00000171759","variantFunctionalConsequenceId":"SO_0001819","variantId":"12_102912824_A_C","variantRsId":"rs773425620","cohortPhenotypes":["Folling disease","Oligophrenia phenylpyruvica","Phenylketonuria","Phenylketonurias"],"diseaseFromSource":"Phenylketonuria","diseaseFromSourceId":"C0031485","diseaseFromSourceMappedId":"MONDO_0009861","variantHgvsId":"NC_000012.12:g.102912824A>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV001861075","releaseDate":"2022-03-28","targetFromSourceId":"ENSG00000138622","variantFunctionalConsequenceId":"SO_0001583","variantId":"15_73324179_T_G","variantRsId":"rs1161776375","cohortPhenotypes":["Brugada syndrome 8"],"diseaseFromSource":"Brugada syndrome 8","diseaseFromSourceId":"C2751083","diseaseFromSourceMappedId":"MONDO_0013148","variantHgvsId":"NC_000015.10:g.73324179T>G"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV002138447","releaseDate":"2022-04-08","targetFromSourceId":"ENSG00000162065","variantFunctionalConsequenceId":"SO_0001627","variantId":"16_2499947_G_A","variantRsId":"rs1173044946","cohortPhenotypes":["Autosomal dominant nonsyndromic hearing loss 65","Caused by mutation in the TBC1 domain family, member 24","Deafness, autosomal dominant 65","Developmental and epileptic encephalopathy, 1","Epileptic encephalopathy, early infantile, 1","INFANTILE SPASM SYNDROME, X-LINKED 1","OHTAHARA SYNDROME, X-LINKED","Tonic spasms with clustering, arrest of psychomotor development and hypsarrhythmia on EEG","West's syndrome","X-Linked Infantile Spasm Syndrome","X-linked infantile spasms"],"diseaseFromSource":"Developmental and epileptic encephalopathy, 1","diseaseFromSourceId":"C3463992","diseaseFromSourceMappedId":"Orphanet_364063","variantHgvsId":"NC_000016.10:g.2499947G>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV002933690","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000165280","variantFunctionalConsequenceId":"SO_0001819","variantId":"9_35063060_A_C","variantRsId":null,"cohortPhenotypes":["Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia","Frontotemporal dementia and/or amyotrophic lateral sclerosis 6","Inclusion body myopathy with Paget disease of bone and frontotemporal dementia","Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia","VCP-Related Amyotrophic Lateral Sclerosis","VCP-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia"],"diseaseFromSource":"Inclusion body myopathy with Paget disease of bone and frontotemporal dementia","diseaseFromSourceId":"C1833662","diseaseFromSourceMappedId":"Orphanet_52430","variantHgvsId":"NC_000009.12:g.35063060A>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003804888","releaseDate":"2024-02-28","targetFromSourceId":"ENSG00000178209","variantFunctionalConsequenceId":"SO_0001819","variantId":"8_143920449_G_A","variantRsId":null,"cohortPhenotypes":["Autosomal recessive limb-girdle muscular dystrophy type 2Q","EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE","EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY","Epidermolysa bullosa simplex and limb girdle muscular dystrophy","Epidermolysis bullosa simplex 5B, with muscular dystrophy","Epidermolysis bullosa simplex 5C, with pyloric atresia","Epidermolysis bullosa simplex with muscular dystrophy","Epidermolysis bullosa simplex with nail dystrophy","Epidermolysis bullosa simplex with pyloric atresia","Epidermolysis bullosa simplex, Ogna type","Limb-girdle muscular dystrophy, type 2Q","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17","PLEC1-Related Epidermolysis Bullosa with Pyloric Atresia","Pidermolysis bullosa simplex 5A, Ogna type"],"diseaseFromSource":"Epidermolysis bullosa simplex 5B, with muscular dystrophy","diseaseFromSourceId":"C2931072","diseaseFromSourceMappedId":"Orphanet_257","variantHgvsId":"NC_000008.11:g.143920449G>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003805362","releaseDate":"2024-02-28","targetFromSourceId":"ENSG00000101310","variantFunctionalConsequenceId":"SO_0002169","variantId":"20_18515639_C_T","variantRsId":null,"cohortPhenotypes":["CDA 2","Congenital dyserythropoietic anemia, type II","Cowden syndrome 7","Dyserythropoietic anemia, congenital type 2","HEMPAS anemia","Hereditary Erythroblastic Multinuclearity with Positive Acidified-Serum test'"],"diseaseFromSource":"Cowden syndrome 7","diseaseFromSourceId":"C4225179","diseaseFromSourceMappedId":"MONDO_0014802","variantHgvsId":"NC_000020.11:g.18515639C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV003806863","releaseDate":"2024-02-28","targetFromSourceId":"ENSG00000134569","variantFunctionalConsequenceId":"SO_0001574","variantId":"11_46883977_C_T","variantRsId":null,"cohortPhenotypes":["Cenani syndactylism","Cenani-Lenz syndactyly syndrome","Congenital myasthenic syndrome 17","SYNDACTYLY, TYPE VII","Sclerosteosis 2","Syndactyly Cenani Lenz type","Syndactyly type 7"],"diseaseFromSource":"Sclerosteosis 2","diseaseFromSourceId":"C3280402","diseaseFromSourceMappedId":"MONDO_0013679","variantHgvsId":"NC_000011.10:g.46883977C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV003850101","releaseDate":"2024-02-28","targetFromSourceId":"ENSG00000054983","variantFunctionalConsequenceId":"SO_0002169","variantId":"14_87988221_T_C","variantRsId":null,"cohortPhenotypes":["Galactocerebrosidase deficiency","Galactosylceramide beta-galactosidase deficiency","Globoid cell leukoencephalopathy","Krabbe leukodystrophy","Leukodystrophy, Globoid Cell"],"diseaseFromSource":"Galactosylceramide beta-galactosidase deficiency","diseaseFromSourceId":"C0023521","diseaseFromSourceMappedId":"MONDO_0009499","variantHgvsId":"NC_000014.9:g.87988221T>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV001944434","releaseDate":"2022-03-28","targetFromSourceId":"ENSG00000178209","variantFunctionalConsequenceId":"SO_0001583","variantId":"8_143917391_C_T","variantRsId":"rs541897170","cohortPhenotypes":["Autosomal recessive limb-girdle muscular dystrophy type 2Q","EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE","EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY","Epidermolysa bullosa simplex and limb girdle muscular dystrophy","Epidermolysis bullosa simplex 5B, with muscular dystrophy","Epidermolysis bullosa simplex 5C, with pyloric atresia","Epidermolysis bullosa simplex with muscular dystrophy","Epidermolysis bullosa simplex with nail dystrophy","Epidermolysis bullosa simplex with pyloric atresia","Epidermolysis bullosa simplex, Ogna type","Limb-girdle muscular dystrophy, type 2Q","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17","PLEC1-Related Epidermolysis Bullosa with Pyloric Atresia","Pidermolysis bullosa simplex 5A, Ogna type"],"diseaseFromSource":"Autosomal recessive limb-girdle muscular dystrophy type 2Q","diseaseFromSourceId":"C3150989","diseaseFromSourceMappedId":"Orphanet_254361","variantHgvsId":"NC_000008.11:g.143917391C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV000547369","releaseDate":"2017-12-26","targetFromSourceId":"ENSG00000008056","variantFunctionalConsequenceId":"SO_0001819","variantId":"X_47574166_C_T","variantRsId":"rs967215240","cohortPhenotypes":["Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders","Epilepsy, X-linked, with variable learning disabilities and behavior disorders","X-linked epilepsy-learning disabilities-behavior disorders syndrome"],"diseaseFromSource":"Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders","diseaseFromSourceId":"C5774177","diseaseFromSourceMappedId":"MONDO_0010339","variantHgvsId":"NC_000023.11:g.47574166C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["uncertain significance"],"confidence":"criteria provided, single submitter","studyId":"RCV002912729","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000173040","variantFunctionalConsequenceId":"SO_0001583","variantId":"4_5640686_T_C","variantRsId":null,"cohortPhenotypes":["Acrofacial dysostosis of Weyers","Chondroectodermal dysplasia","Curry-Hall syndrome","Ellis-van Creveld syndrome","Mesoectodermal dysplasia","WEYERS ACRODENTAL DYSOSTOSIS"],"diseaseFromSource":"Ellis-van Creveld syndrome","diseaseFromSourceId":"C0013903","diseaseFromSourceMappedId":"Orphanet_289","variantHgvsId":"NC_000004.12:g.5640686T>C"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely benign"],"confidence":"criteria provided, single submitter","studyId":"RCV002933106","releaseDate":"2023-02-07","targetFromSourceId":"ENSG00000187535","variantFunctionalConsequenceId":"SO_0001819","variantId":"16_1523551_C_T","variantRsId":null,"cohortPhenotypes":["Conorenal syndrome","Renal dysplasia, retinal pigmentary dystrophy, cerebellar ataxia and skeletal dysplasia","SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY","SHORT-RIB THORACIC DYSPLASIA 9 WITHOUT POLYDACTYLY","Saldino-Mainzer syndrome"],"diseaseFromSource":"Saldino-Mainzer syndrome","diseaseFromSourceId":"C1849437","diseaseFromSourceMappedId":"Orphanet_140969","variantHgvsId":"NC_000016.10:g.1523551C>T"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV003398441","releaseDate":"2023-11-20","targetFromSourceId":"ENSG00000123191","variantFunctionalConsequenceId":"SO_0001583","variantId":"13_51958333_C_A","variantRsId":"rs28942074","cohortPhenotypes":["ATP7B-related condition","ATP7B-related disorder"],"diseaseFromSource":"ATP7B-related disorder","diseaseFromSourceId":null,"diseaseFromSourceMappedId":null,"variantHgvsId":"NC_000013.11:g.51958333C>A"}
{"alleleOrigins":["germline"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["likely pathogenic","pathogenic"],"confidence":"criteria provided, multiple submitters, no conflicts","studyId":"RCV000116005","releaseDate":"2014-05-17","targetFromSourceId":"ENSG00000183765","variantFunctionalConsequenceId":"SO_0001587","variantId":"22_28687974_G_A","variantRsId":"rs200432447","cohortPhenotypes":["Cancer predisposition","Hereditary Cancer Syndrome","Hereditary cancer-predisposing syndrome","Hereditary neoplastic syndrome","Neoplastic Syndromes, Hereditary","Tumor predisposition"],"diseaseFromSource":"Hereditary cancer-predisposing syndrome","diseaseFromSourceId":"C0027672","diseaseFromSourceMappedId":"MONDO_0015356","variantHgvsId":"NC_000022.11:g.28687974G>A"}
{"alleleOrigins":["de novo"],"datasourceId":"eva","datatypeId":"genetic_association","clinicalSignificances":["pathogenic"],"confidence":"criteria provided, single submitter","studyId":"RCV000855501","releaseDate":"2019-11-08","targetFromSourceId":"ENSG00000152217","variantFunctionalConsequenceId":"SO_0001583","variantId":"18_44951952_T_C","variantRsId":"rs267607038","cohortPhenotypes":["Arthrogryposis multiplex congenita","Congenital arthromyodysplasia","Congenital multiple arthrogryposis","Fetal akinesia deformation sequence 1","Fetal akinesia sequence","Fibrous ankylosis of multiple joints","Guerin-Stern syndrome","Guérin-Stern syndrome","Lethal Pena-Shokeir 1 syndrome","Myodystrophia fetalis deformans","Otto syndrome","Pena Shokeir syndrome, type 1","Pena-Shokeir syndrome type I","Rocher-Sheldon syndrome","Rossi syndrome"],"diseaseFromSource":"Fetal akinesia deformation sequence 1","diseaseFromSourceId":"C1276035","diseaseFromSourceMappedId":"Orphanet_994","variantHgvsId":"NC_000018.10:g.44951952T>C"}
